Dermatologic Disease of Inpatients in Internal Medicine Clinical Trial
| Verified date | January 2011 |
| Source | University of Zurich |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Switzerland: UZurich |
| Study type | Observational |
This is a 3 months single centre clinical patient-oriented study to evaluate the prevalence
and impairment in QOL of dermatologic diseases in patients hospitalised in internal
medicine.
Up to 200 patients hospitalised at the division of internal medicine for any reason are
going to be offered participation by a patient information form given to patients at the
time of admission, as well as oral information about the study. Written informed consent
will be obtained by the investigators after patients have had adequate time to consider
their participation in the study.
Participating patients will be examined clinically for dermatologic pathologies at a single
visit. In the case of signs of dermatologic disease, investigators are going to recommend
further diagnostic procedures to the physician in charge and/or the referring physician,
depending on the urgency of the suspected diagnosis. This procedure is meant to avoid giving
referring physicians the impression that active patient acquisition for the department of
Dermatology is an aim of this study. Diagnostic procedures that are performed upon suspicion
of a specific dermatologic disease at the Division of Internal Medicine are going to be
performed during the hospitalisation period. All other diagnostic or operative procedures
are going to be advised to the referring physician.
Study participants are going to be interviewed by the investigators about impairment in QOL
of their illnesses. Two separate questionnaires are going to be filled in by each
participant. For measurement of general QOL, the widely used SF-12 questionnaire (8
questions) is going to be used. To measure specific impairment in QOL by dermatologic
disease, participants are going to be asked to fill in the DLQI (Dermatology life quality
index, 10 questions). Photographic documentation of specific identified lesions will be made
and pictures stored exclusively in the secured electronic patient file (KISIM). Medication
and all identified diseases will be noted. All diagnostically useful information is going to
be recorded in the patient file and transmitted to the referring physician in the discharge
letter.
| Status | Completed |
| Enrollment | 200 |
| Est. completion date | December 2010 |
| Est. primary completion date | January 2010 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion criteria: Patients will be eligible for enrolment if they fulfil the following
criteria: 1. Male or female patients, age ? 18 years of age and 2. Hospitalised at the Division of Internal Medicine, University Hospital Zurich 3. Patients must be able to give written informed consent before any trial-specific procedures are performed (see Section 12.2). Exclusion criteria: Patients will be excluded from the study if they fulfill any of the following criteria: 1. Ability to communicate orally severely impaired due to any reason, namely illness or inability to speak German. 2. Terminal patients or other patients where participation in a visit with oral and physical examination would represent an unreasonable exertion. 3. Pregnant women |
Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| University of Zurich |
Switzerland,